Structured Review

SeraCare hcv rna
Accuracy across the linear range of the CAP/CTM <t>HCV</t> test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored <t>RNA,</t> genotype 1; light gray diamonds, 3rd WHO HCV RNA international
Hcv Rna, supplied by SeraCare, used in various techniques. Bioz Stars score: 92/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcv rna/product/SeraCare
Average 92 stars, based on 2 article reviews
Price from $9.99 to $1999.99
hcv rna - by Bioz Stars, 2020-05
92/100 stars

Images

1) Product Images from "Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design"

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

Journal: Journal of Clinical Microbiology

doi: 10.1128/JCM.01784-12

Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international
Figure Legend Snippet: Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international

Techniques Used:

Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single
Figure Legend Snippet: Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single

Techniques Used:

Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line
Figure Legend Snippet: Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line

Techniques Used:

2) Product Images from "Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design"

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

Journal: Journal of Clinical Microbiology

doi: 10.1128/JCM.01784-12

Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international
Figure Legend Snippet: Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international

Techniques Used:

Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single
Figure Legend Snippet: Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single

Techniques Used:

Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line
Figure Legend Snippet: Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line

Techniques Used:

3) Product Images from "Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design"

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

Journal: Journal of Clinical Microbiology

doi: 10.1128/JCM.01784-12

Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international
Figure Legend Snippet: Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international

Techniques Used:

Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single
Figure Legend Snippet: Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single

Techniques Used:

Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line
Figure Legend Snippet: Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line

Techniques Used:

4) Product Images from "Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design"

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

Journal: Journal of Clinical Microbiology

doi: 10.1128/JCM.01784-12

Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international
Figure Legend Snippet: Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international

Techniques Used:

Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single
Figure Legend Snippet: Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single

Techniques Used:

Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line
Figure Legend Snippet: Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line

Techniques Used:

5) Product Images from "Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design"

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

Journal: Journal of Clinical Microbiology

doi: 10.1128/JCM.01784-12

Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international
Figure Legend Snippet: Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international

Techniques Used:

Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single
Figure Legend Snippet: Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single

Techniques Used:

Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line
Figure Legend Snippet: Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line

Techniques Used:

6) Product Images from "Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design"

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

Journal: Journal of Clinical Microbiology

doi: 10.1128/JCM.01784-12

Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international
Figure Legend Snippet: Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international

Techniques Used:

Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single
Figure Legend Snippet: Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single

Techniques Used:

Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line
Figure Legend Snippet: Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line

Techniques Used:

7) Product Images from "Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design"

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

Journal: Journal of Clinical Microbiology

doi: 10.1128/JCM.01784-12

Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international
Figure Legend Snippet: Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international

Techniques Used:

Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single
Figure Legend Snippet: Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single

Techniques Used:

Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line
Figure Legend Snippet: Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line

Techniques Used:

8) Product Images from "Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design"

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

Journal: Journal of Clinical Microbiology

doi: 10.1128/JCM.01784-12

Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international
Figure Legend Snippet: Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international

Techniques Used:

Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single
Figure Legend Snippet: Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single

Techniques Used:

Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line
Figure Legend Snippet: Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line

Techniques Used:

Related Articles

Polymerase Chain Reaction:

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design
Article Snippet: .. To test for PCR interference, elevated levels of triglycerides (3,300 mg/dl), conjugated bilirubin (25 mg/dl), unconjugated bilirubin (20 mg/dl), albumin (6,000 mg/dl), hemoglobin (200 mg/dl), and human DNA (40 mg/dl), as well as autoimmune disease markers (systemic lupus erythematosus, rheumatic factor, and antinuclear antibody), were tested with the CAP/CTM HCV test, v2.0, in HCV RNA-negative individual donors with and without EDTA plasma specimens spiked with HCV RNA (Seracare Life Sciences, Milford, MA) at a concentration of 45 IU/ml. ..

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design
Article Snippet: .. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS AmpliPrep/COBAS TaqMan) for quantification of HCV RNA . ..

Concentration Assay:

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design
Article Snippet: .. To test for PCR interference, elevated levels of triglycerides (3,300 mg/dl), conjugated bilirubin (25 mg/dl), unconjugated bilirubin (20 mg/dl), albumin (6,000 mg/dl), hemoglobin (200 mg/dl), and human DNA (40 mg/dl), as well as autoimmune disease markers (systemic lupus erythematosus, rheumatic factor, and antinuclear antibody), were tested with the CAP/CTM HCV test, v2.0, in HCV RNA-negative individual donors with and without EDTA plasma specimens spiked with HCV RNA (Seracare Life Sciences, Milford, MA) at a concentration of 45 IU/ml. ..

other:

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design
Article Snippet: A result between the LOD and the LLoQ was reported as > 15 and < 43 IU/ml HCV RNA detected.

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design
Article Snippet: It is important to note that, regardless of whether the LOD is equal to or below the LLoQ, HCV RNA can be detected below this level.

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design
Article Snippet: For example, at 5 IU/ml, HCV RNA is still detectable approximately 70% of the time if the same sample is measured several times ( ).

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design
Article Snippet: Furthermore, any result that is not detected (e.g., “0 IU/ml”) will be reported as “target not detected,” a result that is distinct from “HCV RNA detected, < 15 IU/ml” ( , , ).

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design
Article Snippet: The 25 serum and EDTA plasma samples that were previously found to contain no detectable HCV RNA were all negative by the CAP/CTM HCV test, v2.0.

Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design
Article Snippet: The new assay reports HCV RNA levels of 1 to 14 IU/ml as “HCV RNA detected, below the LLoQ.” This should simplify the results obtained with this new assay and eliminate confusion by providing a single value for both the LOD and LLoQ, making it easier for laboratories and clinicians to interpret the results of DAA treatments ( , ).

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92
    SeraCare hcv rna
    Accuracy across the linear range of the CAP/CTM <t>HCV</t> test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored <t>RNA,</t> genotype 1; light gray diamonds, 3rd WHO HCV RNA international
    Hcv Rna, supplied by SeraCare, used in various techniques. Bioz Stars score: 92/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcv rna/product/SeraCare
    Average 92 stars, based on 2 article reviews
    Price from $9.99 to $1999.99
    hcv rna - by Bioz Stars, 2020-05
    92/100 stars
      Buy from Supplier

    Image Search Results


    Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international

    Journal: Journal of Clinical Microbiology

    Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

    doi: 10.1128/JCM.01784-12

    Figure Lengend Snippet: Accuracy across the linear range of the CAP/CTM HCV test, v2.0, measured in EDTA plasma (a) and serum (b) matrices. Open diamonds, genotype 1 clinical specimen; black diamonds, armored RNA, genotype 1; light gray diamonds, 3rd WHO HCV RNA international

    Article Snippet: A result between the LOD and the LLoQ was reported as > 15 and < 43 IU/ml HCV RNA detected.

    Techniques:

    Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single

    Journal: Journal of Clinical Microbiology

    Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

    doi: 10.1128/JCM.01784-12

    Figure Lengend Snippet: Deming regression analysis (a) and Bland-Altman analysis (b) of the CAP/CTM HCV test, v2.0, versus the CAP/CTM HCV test for HCV RNA genotypes 1 to 6 and for only genotype 4 in panels c and d. The dotted line (a, c) represents the line of unity, and single

    Article Snippet: A result between the LOD and the LLoQ was reported as > 15 and < 43 IU/ml HCV RNA detected.

    Techniques:

    Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line

    Journal: Journal of Clinical Microbiology

    Article Title: Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

    doi: 10.1128/JCM.01784-12

    Figure Lengend Snippet: Determination of the linear range of the CAP/CTM HCV test, v2.0, with EDTA plasma (a) and serum (b) matrices. Filled diamonds, clinical samples; open diamonds, armored RNA samples; bold line (from 11 to 1.2E+08 IU/ml), regression line; gray line, line

    Article Snippet: A result between the LOD and the LLoQ was reported as > 15 and < 43 IU/ml HCV RNA detected.

    Techniques: